Goldman Sachs Group Inc Kura Oncology, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 933,670 shares of KURA stock, worth $9.46 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
933,670
Previous 828,781
12.66%
Holding current value
$9.46 Million
Previous $5.47 Million
1.5%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding KURA
# of Institutions
191Shares Held
79.9MCall Options Held
53.6KPut Options Held
42.8K-
Suvretta Capital Management, LLC New York, NY8.12MShares$82.2 Million1.61% of portfolio
-
Bvf Inc San Francisco, CA7.75MShares$78.5 Million1.76% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$70.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.2MShares$62.8 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$54.2 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $678M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...